Literature DB >> 12457281

Entrance in mitosis of adult cardiomyocytes in ischemic pig hearts after plasmid-mediated rhVEGF165 gene transfer.

R Laguens1, P Cabeza Meckert, G Vera Janavel, H Del Valle, E Lascano, J Negroni, P Werba, L Cuniberti, V Martínez, C Melo, M Papouchado, R Ojeda, M Criscuolo, A Crottogini.   

Abstract

Replacement of the cell loss occurring after acute myocardial infarction has been proposed as a potential treatment to prevent heart remodeling and failure. On account that cardiomyocytes express VEGF receptors and that VEGF triggers mitogen-activated protein kinases, we investigated if VEGF gene transfer may induce cardiomyocyte replication. In a pig model of chronic myocardial ischemia achieved by Ameroid occlusion of the left circumflex coronary artery, we observed that direct intramyocardial injection of a plasmid encoding human VEGF(165) induced a several-fold increase in cardiomyocyte mitotic index and in the number of cardiomyocyte nuclei per unit volume as compared with pigs receiving plasmid devoid of gene. Despite images of conventional cytokinesis were not observed, the fact that caryokinesis is an obligatory step for cell division suggests that our finding may contribute to the issue of heart regeneration and may potentially widen the therapeutic spectrum of VEGF gene transfer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12457281     DOI: 10.1038/sj.gt.3301844

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  17 in total

Review 1.  The paracrine effect: pivotal mechanism in cell-based cardiac repair.

Authors:  Simon Maltais; Jacques P Tremblay; Louis P Perrault; Hung Q Ly
Journal:  J Cardiovasc Transl Res       Date:  2010-06-08       Impact factor: 4.132

2.  Intramyocardial VEGF-B167 gene delivery delays the progression towards congestive failure in dogs with pacing-induced dilated cardiomyopathy.

Authors:  Martino Pepe; Mohammed Mamdani; Lorena Zentilin; Anna Csiszar; Khaled Qanud; Serena Zacchigna; Zoltan Ungvari; Uday Puligadda; Silvia Moimas; Xiaobin Xu; John G Edwards; Thomas H Hintze; Mauro Giacca; Fabio A Recchia
Journal:  Circ Res       Date:  2010-04-29       Impact factor: 17.367

3.  Mesenchymal stromal cells overexpressing vascular endothelial growth factor in ovine myocardial infarction.

Authors:  P Locatelli; F D Olea; A Hnatiuk; A De Lorenzi; M Cerdá; C S Giménez; D Sepúlveda; R Laguens; A Crottogini
Journal:  Gene Ther       Date:  2015-03-19       Impact factor: 5.250

Review 4.  Optimizing stem cell function for the treatment of ischemic heart disease.

Authors:  Jeremy L Herrmann; Aaron M Abarbanell; Brent R Weil; Mariuxi C Manukyan; Jeffrey A Poynter; Benjamin J Brewster; Yue Wang; Daniel R Meldrum
Journal:  J Surg Res       Date:  2010-06-16       Impact factor: 2.192

Review 5.  Cardiovascular gene therapy for myocardial infarction.

Authors:  Maria C Scimia; Anna M Gumpert; Walter J Koch
Journal:  Expert Opin Biol Ther       Date:  2013-12-16       Impact factor: 4.388

6.  Genetic modification of embryonic stem cells with VEGF enhances cell survival and improves cardiac function.

Authors:  Xiaoyan Xie; Feng Cao; Ahmad Y Sheikh; Zongjin Li; Andrew J Connolly; Xuetao Pei; Ren-Ke Li; Robert C Robbins; Joseph C Wu
Journal:  Cloning Stem Cells       Date:  2007

7.  Adeno-associated viral vector-mediated hypoxia-regulated VEGF gene transfer promotes angiogenesis following focal cerebral ischemia in mice.

Authors:  F Shen; Y Fan; H Su; Y Zhu; Y Chen; W Liu; W L Young; G-Y Yang
Journal:  Gene Ther       Date:  2007-10-25       Impact factor: 5.250

Review 8.  Contemporary Animal Models For Human Gene Therapy Applications.

Authors:  Chitra Gopinath; Trupti Job Nathar; Arkasubhra Ghosh; Dennis Durand Hickstein; Everette Jacob Remington Nelson
Journal:  Curr Gene Ther       Date:  2015       Impact factor: 4.391

Review 9.  Cardiovascular gene therapy: current status and therapeutic potential.

Authors:  M M Gaffney; S O Hynes; F Barry; T O'Brien
Journal:  Br J Pharmacol       Date:  2007-06-11       Impact factor: 8.739

10.  Ablation of phospholamban rescues reperfusion arrhythmias but exacerbates myocardium infarction in hearts with Ca2+/calmodulin kinase II constitutive phosphorylation of ryanodine receptors.

Authors:  Carlos A Valverde; Gabriela Mazzocchi; Mariano N Di Carlo; Alejandro Ciocci Pardo; Nehuen Salas; María Ines Ragone; Juan I Felice; Alejandra Cely-Ortiz; Alicia E Consolini; Enrique Portiansky; Susana Mosca; Evangelia G Kranias; Xander H T Wehrens; Alicia Mattiazzi
Journal:  Cardiovasc Res       Date:  2019-03-01       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.